肿瘤转移抑制蛋白在舌鳞状细胞癌中的表达与临床意义

doi:10.6040/j.issn.1673-3770.0.2018.465

摘要/Abstract

摘要： 目的研究肿瘤转移抑制蛋白1(MTSS1)在舌鳞状细胞癌、癌旁正常组织中的表达及其意义。方法应用免疫组织化学方法检测舌鳞状细胞癌、癌旁正常组织中MTSS1蛋白的表达,并用单因素分析法研究其与临床病理因素的关系。结果 20例舌鳞状细胞癌组织中MTSS1的蛋白表达水平与20例配对癌旁正常组织相比,差异有统计学意义(P=0.005);34例转移组中MTSS1的蛋白表达水平与46例非转移组相比,差异有统计学意义(P =0.033);37例临床Ⅲ~Ⅳ期组中MTSS1的蛋白表达水平与43例临床Ⅰ~Ⅱ期组相比,差异有统计学意义(P<0.001)。结论 MTSS1蛋白在舌鳞状细胞癌的早期进展中发挥了重要作用,MTSS1蛋白表达水平的降低可能与舌鳞状细胞癌的浸润转移有关,可能抑制了TSCC的发生和发展。

关键词: 肿瘤转移抑制蛋白1, 舌鳞状细胞癌, 免疫组织化学, 转移, 蛋白表达

Abstract: Objective To compare the expression of metastasis suppressor 1(MTSS1)protein in tongue squamous cell carcinoma(TSCC)and normal tongue mucosa. Methods The expression of MTSS1 was analyzed in TSCC and normal tongue mucosa using immunohistochemical staining. Single-factor analysis was used to study the relationship between MTSS1 expression and clinicopathological factors. Results The expression of MTSS1 was lower in TSCC than in normal tongue mucosa(20 cases each). The expression of MTSS1 was higher in cases with positive lymph node metastasis(34 cases)than those negative for lymph node metastasis(46 cases). Furthermore, the expression of MTSS1 was higher in cases with higher clinical stage(37 cases)than in those with lower clinical stage(43 cases). Conclusion The decrease of MTSS1 expression may be associated with infiltration and metastasis of TSCC. MTSS1 may inhibit the occurrence and development of TSCC and play an important role in the early development of TSCC.

Key words: Metastasis suppressor 1, Tongue squamous cell carcinoma, Immunohistochemistry, Metastasis, Protein expression

中图分类号:

R766.49

蒋宁宁,王鹏来,袁长勇,黄晓峰,蒋常委,刘宗响,孙铁忠. 肿瘤转移抑制蛋白在舌鳞状细胞癌中的表达与临床意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 64-67.

JIANG Ningning, WANG Penglai, YUAN Changyong, HUANG Xiaofeng, JIANG Changwei, LIU Zongxiang,SUN Tiezhong. The expression and significance of metastasis suppressor 1 protein in tongue squamous cell carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 64-67.

参考文献

[1] Lee YG, Macoska JA, Korenchuk S, et al. MIM, a potential metastasis suppressor gene in bladder cancer[J]. Neoplasia, 2002, 4(4): 291-294. doi:10.1038/sj.neo.7900231.
[2] Dawson JC, Bruche S, Spence HJ, et al. Mtss1 promotes cell-cell junction assembly and stability through the small GTPase Rac1[J]. PLoS One, 2012, 7(3): e31141. doi:10.1371/journal.pone.0031141.
[3] Xie W, Sun F, Chen L, et al. MiR-96 promotes breast cancer metastasis by suppressing MTSS1[J]. Oncol Lett, 2018, 15(3): 3464-3471. doi:10.3892/ol.2018.7728.
[4] Xu MW, Xu T. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma[J]. Oncol Lett, 2018, 16(1): 371-377. doi:10.3892/ol.2018.8657.
[5] Xu N, Yang WL, Liu Y, et al. MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression[J]. Environ Sci Pollut Res Int, 2018, 25(12): 12064-12071. doi:10.1007/s11356-018-1331-9.
[6] Schemionek M, Herrmann O, Reher MM, et al. Mtss1 is a critical epigenetically regulated tumor suppressor in CML[J]. Leukemia, 2016, 30(4): 823-832. doi:10.1038/leu.2015.329.
[7] Liu R, Martin TA, Jordan NJ, et al. Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis[J]. Int J Oncol, 2015, 47(4): 1429-1439. doi:10.3892/ijo.2015.3121.
[8] Guo Y, Ren MS, Shang C, et al. MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line[J]. Int J Clin Exp Med, 2015, 8(9): 15441-15449.
[9] Zhang SD, Qi QG. MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma[J]. J Neurooncol, 2015, 121(3): 425-431. doi:10.1007/s11060-014-1656-2.
[10] Zeleniak AE, Huang W, Brinkman MK, et al. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer[J]. Oncotarget, 2017, 8(10): 16473-16487. doi:10.18632/oncotarget.14869.
[11] Huang XY, Huang ZL, Xu B, et al. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2016, 35(1): 85. doi:10.1186/s13046-016-0361-8.
[12] Zhang J, Tong Y, Ren L, et al. Expression of metastasis suppressor 1 in cervical carcinoma and the clinical significance[J]. Oncol Lett, 2014, 8(5): 2145-2149. doi:10.3892/ol.2014.2508.
[13] 张思, 李雪, 刘元林, 等. 宫颈癌中MTSS1基因与Shh信号通路的关系研究[J]. 军事医学, 2016, 40(6): 484-487. doi:10.7644/j.issn.1674-9960.2016.06.008.
[14] Peng Du, Lin Ye, Han Li. The tumour suppressive role of Metastasis Suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway[J]. J Exp Ther Oncol,2012,10(2): 91-99.
[15] Callahan CA, Ofstad T, Horng L, et al. MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription[J]. Genes Dev, 2004, 18(22): 2724-2729. doi:10.1101/gad.1221804.
[16] Kedmi M, Ben-Chetrit N, Körner C, et al. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer[J]. Sci Signal, 2015, 8(368): ra29. doi:10.1126/scisignal.2005866.
[17] Lei R, Tang J, Zhuang X, et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis[J]. Oncogene, 2014, 33(10): 1287-1296. doi:10.1038/onc.2013.65.
[18] Vadakekolathu J, Al-Juboori SIK, Johnson C, et al. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer[J]. Cell Death Dis, 2018, 9(3): 344. doi:10.1038/s41419-018-0364-9.

相关文章 15

[1]	李林,张衡,冼宇飞,盛晓丽. 长链非编码RNA在鼻咽癌组织中表达及其生物学功能研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 69-72.
[2]	高晓倩,姜震,耿琛琛,刘大昱,李荔. 术前超声评估分化型甲状腺癌颈部淋巴结转移[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 135-139.
[3]	何健,钱立庭,高劲. 外耳道腺样囊性癌侵犯中耳、颞叶且伴颈部淋巴结转移一例报告[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 109-111.
[4]	李浩,李延忠,王岩. HIF-1α、VEGF在阻塞性睡眠呼吸暂停低通气综合征患者[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 43-47.
[5]	朱晓城,钱晓云,顾亚军,沈晓辉,宋盼盼,李惠,高下. MGMT和EGFR蛋白在喉鳞状细胞癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 68-72.
[6]	安永明,穆文利,田艳勋,李伟,吴彦桥. 喉鳞癌组织中抑癌基因Maspin和转录因子Ets1的表达及意义[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 91-94.
[7]	余济春. 分化型甲状腺癌颈淋巴结清扫术[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 10-12.
[8]	江昌,许承弼,辛丁,鞠洋,李鸿燕,王金月. 下咽癌腋窝淋巴结转移1例及文献回顾[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 90-92.
[9]	李富, 赵书佑. 肺癌肿瘤抑制因子-1在喉鳞癌组织中的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 36-38.
[10]	张剑伟, 张其昌, 庄汉, 倪泽, 蔡维奇. 上颌窦内肾透明细胞癌转移1例报道[J]. 山东大学耳鼻喉眼学报, 2014, 28(6): 96-97.
[11]	贾传亮1,2，张丽净2,3综述,宋西成2审校. MGMT基因与头颈肿瘤的相关研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(3): 80-85.
[12]	魏希建1，阴瑞兰2，郭星3. 增殖诱导配体在喉鳞状细胞癌中的表达[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 14-16.
[13]	徐禛1，于海玲1，刘冰2. 水通道蛋白-4在人鼻息肉组织中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 48-50.
[14]	罗小邹综述,洪育明审校. 候选转移抑制基因(MTSS1)与肿瘤关系的研究进展[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 79-83.
[15]	周鹏，贺青卿，庄大勇，范子义，郑鲁明，朱见，于芳，岳涛，董学峰. 甲状腺乳头状癌颈部淋巴结转移规律的临床分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 12-15.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed